Effect of dibutyryl cyclic AMP on plasma renin activity in normal men and patients with primary aldosteronism

Journal of Endocrinological Investigation

Volumn 20, Issue 1, 1997, Pages 13-17

  Fukuda, N ^a   Soma, M ^a   Kubo, A ^a   Kunimoto, M ^a   Watanabe, Y ^a   Izumi, Y ^a   Kanmatsuse, K ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Aldosteronism; Dibutyryl cyclic AMP; Human; Renin

Indexed keywords

BUCLADESINE; POTASSIUM ION; RENIN; SODIUM ION;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRIMARY HYPERALDOSTERONISM; SODIUM BLOOD LEVEL; SODIUM EXCRETION; URINE VOLUME;

EID: 0030895431     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347966     Document Type: Article

References (21)

1. Torretti J. Sympathetic control of renin release. Annu. Rev. Pharmacol. Toxicol. 22: 167, 1982.
2. KeetonT.K., Campbell W.B. The pharmacologic alteration of renin release. Pharmacol. Rev. 32: 81, 1980.
3. Michalakis A.M., Candel J., Liddle G.W. In vitro stimulation of renin production by epinephrine, non-epinephrine and cyclic AMP. Proc. Soc. Exp. Biol. Med. 130: 748, 1969.
4. Pinet F., Mizrahi J., Menard J., Corvol P. Role of cyclic AMP in renin secretion by human transfected juxtaglomerular cells. J. Hypertens. 4(Suppl. 6): S421, 1986.
5. 2'-dibutyryl adenosine cyclic 3′:5′-monophosphate. J. Biol. Chem. 250: 984, 1975.
6. Fukuda N., Honda M., Hatano M. Effects of dibutyryladenosine 3′,5′-monophosphate on steroid biosynthesis in humans. Endocrinol. Jpn. 33: 323, 1986.
7. Fukuda N., Honda M., Hatano M. Role of calcium ion in ACTH-induced steroidogenesis in humans. J. Steroid Biochem. 31: 337, 1988.
8. Bondar N., Cadnapaphornchai P., McDonald F.D., Taher S. Mechanism of effect of dibutyryl cyclic adenosine 3′,5′-monophosphate on canine renal renin release. J. Physiol. 355: 33, 1984.
9. Satoh H., Takahashi K., Toda Y., Satoh S. Prostacyclin-independence in beta-adrenoceptor mediated renin release from dog renal cortical slices. Life Sci. 35: 1519, 1984.
10. 2 and renin release. Effects of glucagon, dopamine and cyclic AMP in dogs. Acta Physiol. Scand. 125: 619, 1985.
11. Suzuki S., Kunitake H. The mechanism of the control of renin release by beta-adrenergic receptors. Jpn. Heart J. 27: 871, 1986.
12. Vander A.J., Carlson J. Mechanism of the effects of furosemide on renin secretion in anesthetized dogs. Circ. Res. 25: 145, 1969.
13. Corsini W.A., Hook J.B., Bailie M.D. Control of renin secretion in the dog. Effects of furosemide on the vascular and macula densa receptors. Circ. Res. 37: 464, 1975.
14. Conn J.W., Rovner D.R., Cohen E.L., Bookstein J.J., Cerny J.C., Lucas CP. Preoperative diagnosis of primary aldosteronism. Arch. Intern. Med. 123: 113, 1969.
15. Webb R.C., Bohr D.F. Relaxation of vascular smooth muscle by isoproterenol, dibutyryl-cyclic AMP and theophylline. J. Pharmacol. Exp. Ther. 217: 26, 1980.
16. Yoshitake T., Asano K., Yamamura H., Yoshitake J., Arai T. Experimental and clinical studies of the hemodynamic and metabolic effects of dibutyryl cyclic AMP. Prog. Clin. Biol. Res. 111: 89, 1983.
17. Gill J.R. Jr, Casper A.J.T. Renal effects of adenosine 3′,5′-monophosphate and dibutyryl 3′,5′-monophosphate. J. Clin. Invest. 50: 1231, 1971.
18. Conn J.W., Cohen E.L., Rovner D.R. Suppressed plasma renin activity in primary aldosteronism. JAMA 90: 213, 1964.
19. De Champlain J., Genest J., Veyrat R., Boucher R. Factors controlling renin release in man. Arch. Intern. Med. 117: 355, 1966.
20. Cox M., Stern R.H. Singer I. The defense against hyperkalemia: the role of insulin and aldosterone. N. Engl. J. Med. 299: 525, 1978.
21. Knox F.G., Burnett J.C. Jr, Kohan D.E., Spielman W.S., Strand J.C. Escape from the sodium retaining effects of mineralocorticoids. Kidney Int. 17: 263, 1980.